Stocks entered a bear market in March, but shares of Biogen (NASDAQ:BIIB) moved higher, rising 2.59% during the month, according to data provided by S&P Global Market Intelligence. Biogen gained as investors sought out shares of companies perceived as safe havens during the coronavirus outbreak.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,